Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Respiratory care

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4187/respcare.04004PMID 26060319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Six-minute walk test in Chinese adults with clinically stable bronchiectasis: association with clinical indices and determinants

  2015cited by this paper
• Six-minute walk distance in Chinese adults with stable bronchiectasis: Association with clinical indices and determinants

  2015cited by this paper
• Impulse oscillometry in adults with bronchiectasis.

  2015cited by this paper
• The Role of Viral Infection in Pulmonary Exacerbations of Bronchiectasis in Adults

  2015cited by this paper
• Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China.

  2015cited by this paper
• The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non‐cystic fibrosis bronchiectasis: A case–control analysis

  2014cited by this paper
• Characterization of Lung Function Impairment in Adults with Bronchiectasis

  2014cited by this paper
• Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.

  2013cited by this paper
• Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

  2013cited by this paper
• Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis

  2013cited by this paper
• Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.

  2013cited by this paper
• Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.

  2012cited by this paper
• Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

  2012cited by this paper
• British Thoracic Society guideline for non-CFbronchiectasis

  2010cited by this paper
• An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

  2009cited by this paper
• Exhaled breath condensate MMP‐9 levels in children with bronchiectasis

  2009cited by this paper
• Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.

  2009cited by this paper
• Assessing response to treatment of exacerbations of bronchiectasis in adults

  2008influential reference
• Quality of life and inflammation in exacerbations of bronchiectasis

  2008cited by this paper
• Severe exacerbations predict excess lung function decline in asthma

  2007cited by this paper
• The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis

  2006cited by this paper
• Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis.

  2006cited by this paper
• Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.

  2006cited by this paper
• Pathogen-host interactions in Pseudomonas aeruginosa pneumonia.

  2005cited by this paper
• Inhaled fluticasone in bronchiectasis: a 12 month study

  2005cited by this paper
• Exacerbations of COPD Diagnosed in Primary Care: Changes in Spirometry and Relationship to Symptoms

  2005influential reference
• Adaptive immunity to nontypeable Haemophilus influenzae.

  2003cited by this paper
• Overexpression of matrix metalloproteinase‐8 and ‐9 in bronchiectatic airways in vivo

  2002cited by this paper
• Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis.

  2002cited by this paper
• Normative values of pulmonary function testing in Chinese adults.

  2002cited by this paper
• Assessment of airway neutrophils by sputum colour: correlation with airways inflammation

  2001cited by this paper
• Neutrophil Inflammation and Activation in Bronchiectasis: Comparison with Pneumonia and Idiopathic Pulmonary Fibrosis

  2000cited by this paper
• Sputum elastase in steady-state bronchiectasis.

  2000cited by this paper
• Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress

  1998cited by this paper
• Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis.

  1998cited by this paper
• Elevated levels of expired breath hydrogen peroxide in bronchiectasis.

  1998cited by this paper
• Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases.

  1992cited by this paper

• Bronchiectasis evaluation 2025: pediatric and adult perspectives.

  2025cites this paper
• PMN‐MDSCs Orchestrate the Immunosuppressive Microenvironment in the Lung and Are Associated With Clinical Outcome in Bronchiectasis

  2025cites this paper
• The cross-sectional area of the pectoralis major muscle and future exacerbations in patients presenting with bronchiectasis exacerbation: a prospective observational study

  2025cites this paper
• Exacerbations of bronchiectasis

  2024cites this paper
• Rethinking bronchiectasis as an inflammatory disease.

  2024cites this paper
• Biomarkers in bronchiectasis

  2024cites this paper
• The impact of smoking on bronchiectasis and its comorbidities

  2024cites this paper
• Unravelling the “frequent exacerbator” phenotype in cystic fibrosis

  2024cites this paper
• Bronchiectasis management in adults: state of the art and future directions

  2024cites this paper
• The characteristics and prognosis of bronchiectasis patients with airflow limitation: a prospective longitudinal study

  2024cites this paper
• A systematic literature review of the clinical and socioeconomic burden of bronchiectasis

  2024cites this paper
• Exacerbation Prevention and Management of Bronchiectasis

  2023cites this paper
• The BED-Pro Tool: facilitating the detection of bronchiectasis exacerbations

  2023cites this paper
• Safety, Tolerability, and Pharmacokinetic Evaluation of Single and Multiple Doses of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Healthy Japanese and White Adults

  2022cites this paper
• Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention

  2022cites this paper
• Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis

  2022cites this paper
• Research advances and clinical management of bronchiectasis: Chinese perspective

  2022cites this paper
• Respiratory pathogens in patients with acute exacerbation of non-cystic fibrosis bronchiectasis from a developing country.

  2021cites this paper
• Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis

  2021cites this paper
• Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management

  2021cites this paper
• Randomised controlled trial of the effect, cost and acceptability of a bronchiectasis self-management intervention

  2020cites this paper
• Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Pseudomonas aeruginosa

  2020cites this paper
• A study of the psychometric properties of the Brazilian-Portuguese version of Bronchiectasis Health Questionnaire.

  2020cites this paper
• Treatment to prevent exacerbations in bronchiectasis: macrolides as first line?

  2019cites this paper
• Brazilian consensus on non-cystic fibrosis bronchiectasis

  2019cites this paper
• The economic burden of bronchiectasis – known and unknown: a systematic review

  2019cites this paper
• Phenotyping bronchiectasis based on aetiology, exacerbation characteristics and response to erythromycin

  2018cites this paper
• Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity

  2018cites this paper
• Bronchiectasis

  2018cites this paper
• Relationship between platelet count, platelet indices, and inflammatory markers in stable and acute exacerbation of bronchiectasis patients

  2018cites this paper
• Plethysmography in patients with bronchiectasis secondary to tuberculosis in a public hospital in Lima, Peru

  2018cites this paper
• Defining severe bronchiectasis

  2018cites this paper
• Pseudomonas aeruginosa and Bronchiectasis

  2018cites this paper
• Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis––experiences from recent clinical trials

  2018cites this paper
• Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis

  2018cites this paper
• Suspecting non‐cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know

  2017cites this paper
• Exacerbation of Bronchiectasis

  2017cites this paper
• Cough and bronchiectasis.

  2017cites this paper